Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details. This indicates restricted access to the trial record.
    Difference
    20%
    Check dated 2026-09-19T20:33:08.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.6.6 (from v3.6.5). This update appears to be a software version change on the site and does not modify the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-29T19:16:01.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.4 to v3.6.5, indicating a platform update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-08T17:06:43.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now displays a newer software revision, updating from v3.6.3 to v3.6.4. This reflects an updated build with no visible changes to study content or layout.
    Difference
    0.1%
    Check dated 2026-07-25T10:27:24.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown on the page, replacing the prior v3.6.2. This indicates a platform version update rather than changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-07-03T22:03:23.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2 instead of Revision: v3.6.0, indicating a software release; the change represents a platform update rather than new or altered trial data.
    Difference
    0.1%
    Check dated 2026-06-26T23:45:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.